The New Jersey Appellate Division recently issued a ruling that adopted the argument that McCarter had made in a medical device products liability case that evidence of the FDA’s 510(k) clearance of the product should be admissible at trial. McCarter & English partner David Kott presented oral argument in the New Jersey Appellate Division while Natalie Mantell and David Kott were on the brief.
3.2.2021